Trevi Therapeutics Inc (NASDAQ:TRVI)
| 1.79 Delayed Data As of Mar 17 |  -0.02 / -1.10%Today’s Change | 1.39 Today|||52-Week Range 4.68 | -7.25% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Tpg Group Holdings Sbs Advisors Inc |  Sale | 7/01/2022 | 436,431 | $2.86 | $1.2M | -38.70% |
Tpg Group Holdings Sbs Advisors Inc | Sale | 6/30/2022 | 429,838 | $2.77 | $1.2M | -36.30% |
Tpg Group Holdings Sbs Advisors Inc | Sale | 7/05/2022 | 63,569 | $3.11 | $197.7K | -46.41% |
Tpg Group Holdings Sbs Advisors Inc | Sale | 6/29/2022 | 46,128 | $2.74 | $126.4K | -26.94% |
Tpg Group Holdings Sbs Advisors Inc | Sale | 4/29/2022 | 16,163 | $2.75 | $44.4K | -33.70% |
Delfini Lisa Chief Financial Officer | Sale | 2/13/2023 | 8,474 | $2.45 | $20.8K | -26.94% |
Tpg Group Holdings Sbs Advisors Inc | Sale | 4/28/2022 | 7,271 | $2.77 | $20.1K | -35.38% |
Delfini Lisa Chief Financial Officer |  Buy | 2/13/2023 | 27,500 | $0.51 | $14.0K | -26.94% |
Farrell Simon Chief Commercial Officer | Buy | 3/07/2023 | 18,750 | $0.51 | $9.6K | -20.44% |
Tpg Group Holdings Sbs Advisors Inc | Sale | 5/02/2022 | 600 | $2.70 | $1.6K | -28.69% |
Page of 2